Regensburg, 2023-06-07: Our recently published study, proofing suitability of a therapeutic HPV vaccine for the treatment of HPV-induced cancer in C57B/l mice , was selected by the UKRs Research Coordination (Forschungsrat) as this month’s “highlight of biomedicial research” (“Glanzlicht der biomedizinischen Forschung” https://www.ukr.de/newsroom/detail/glanzlicht-biomedizinischer-forschung-juni-2023).
For detailled information please see the original paper (https://doi.org/10.1158/2326-6066.CIR-22-0174).
This work was based on a previous publication aiming developing a related vaccine candidate for efficacy testing in non-human primates (https://doi.org/10.3389/fimmu.2021.761214).